Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Monday, November 30, 2009, 3:55AM ET - U.S. Markets open in 5 hours and 35 minutes. Dow Down 1.48% Nasdaq  0.00%
CombinatoRx, Incorporated (CRXX)On Nov 27: 1.11   0.00 (0.00%)  
MORE ON CRXX
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials

HeadlinesGet Headlines for:
Change Display [ hide $$  edit ]
Tue, Nov 24, 2009
FDA delays Combinatorx drug decision
at bizjournals.com (Tue, Nov 24)
CombinatoRx Oncology Programs to Be Highlighted at ASH 2009
Business Wire (Tue, Nov 24)
Fri, Nov 20, 2009
COMBINATORX, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Fri, Nov 20)
FDA Extends NDA Review for Exalgo Extended-Release Tablets
Business Wire (Fri, Nov 20)
Tue, Nov 17, 2009
BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI
at Seeking Alpha (Tue, Nov 17)
Mon, Nov 16, 2009
CombinatoRx Shares Fall as Neuromed Drug Not Approved by FDA
at Fox Business (Mon, Nov 16)
Sprint, CombinatoRx: Early Volume Plays
at TheStreet.com (Mon, Nov 16)
UPDATE - CombinatoRx: Neuromed pain drug may not get approval
at Reuters (Mon, Nov 16)
COMBINATORX, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Mon, Nov 16)
Neuromed Receives FDA Feedback on New Drug Application for Exalgo Extended-Release Tablets
Business Wire (Mon, Nov 16)
Tue, Nov 10, 2009
COMBINATORX, INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Financial Statements and Exhibit
EDGAR Online (Tue, Nov 10)
Sat, Nov 7, 2009
COMBINATORX, INC Financials
EDGAR Online Financials (Sat, Nov 7)
Tue, Nov 3, 2009
CombinatoRx narrows loss on deep R&D cuts
at bizjournals.com (Tue, Nov 3)
COMBINATORX, INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statement
EDGAR Online (Tue, Nov 3)
CombinatoRx Reports Financial Results for the Third Quarter 2009
Business Wire (Tue, Nov 3)
Wed, Oct 21, 2009
Early Movers: Pump Up the Volume
at TheStreet.com (Wed, Oct 21)
COMBINATORX, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Wed, Oct 21)
CombinatoRx'S Synavive (CRx-102) Maintains Efficacy Throughout 12 Month Phase 2 Knee OA Extension Trial
Business Wire (Wed, Oct 21)
Thu, Oct 8, 2009
CombinatoRx Abstract Accepted for Oral Presentation at ACR 2009
Business Wire (Thu, Oct 8)
Mon, Oct 5, 2009
CombinatoRx: Partner Fovea is in talks with Sanofi
AP (Mon, Oct 5)
Older Headlines - Download Recent Headlines
View headlines from:
Add CRXX News to My Yahoo!:
Add to My Yahoo! View RSS Feed

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Headlines for Another Symbol: Symbol Lookup
Stocks In PlayStory Stocks
Full Coverage